PTH and osteoporosis: As the crucial role of osteoporosis mentioned above in implant loosening, it is reasonable and meaningful to detect the effects of approved antiosteoporotic agents, PTH and ZOL, on early-stage periprosthetic osteolysis in patients with poor bone quality.